Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Psychometric evaluation of the Amphetamine Cessation Symptom Assessment|
|Citation:||Journal of Substance Abuse Treatment, 2008; 34(4):443-449|
|Publisher:||Pergamon-Elsevier Science Ltd|
|Catherine McGregor, Manit Srisurapanont, Amanda Mitchell, Marie C. Longo, Sharon Cahill and Jason M. White|
|Abstract:||Testing of a new scale, the Amphetamine Cessation Symptom Assessment (ACSA), in a sample of treatment-seeking amphetamine users (N = 133) showed satisfactory reliability, while factor analysis identified three components explaining 64.7% of the variance in scores. Scores were inversely related to subjective general well-being (r = -.33, p < .01) and directly related to the Beck Depression Inventory (r = .59, p < .01). There were positive relationships between the ACSA and measures of amphetamine dependence (r = .36, p < .01) and the intensity of recent amphetamine use (r = .24, p < .01). The ACSA discriminated between "low-dose" and "high-dose" users, indicating discriminant validity. In inpatients (n = 63), ACSA scores declined significantly over time, while higher scores in inpatient treatment dropouts indicated predictive validity. The ACSA showed satisfactory reliability and validity, with a three-factor solution providing the best fit to the data. The ACSA could play an important role in providing clinical outcome data, particularly in outcome evaluation of new treatment protocols.|
|Keywords:||Humans; Substance-Related Disorders; Amphetamine; Questionnaires; Factor Analysis, Statistical; Reproducibility of Results; Psychometrics; Diagnostic and Statistical Manual of Mental Disorders; Adult; Female; Male|
|Description:||Copyright © 2008 Elsevier Inc. All rights reserved.|
|Appears in Collections:||Pharmacology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.